IL102261A - History of 7-Isoindolinyl-Quinolenic and Naphthyridonecarboxylic Acids, Preparation and Preparation of Pharmaceuticals Containing Them - Google Patents
History of 7-Isoindolinyl-Quinolenic and Naphthyridonecarboxylic Acids, Preparation and Preparation of Pharmaceuticals Containing ThemInfo
- Publication number
- IL102261A IL102261A IL10226192A IL10226192A IL102261A IL 102261 A IL102261 A IL 102261A IL 10226192 A IL10226192 A IL 10226192A IL 10226192 A IL10226192 A IL 10226192A IL 102261 A IL102261 A IL 102261A
- Authority
- IL
- Israel
- Prior art keywords
- methyl
- oxo
- dihydro
- acid
- cyclopropyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL11665692A IL116656A (en) | 1991-06-22 | 1992-06-19 | 4-Amino-1, 3, 3a, 4, 7, 7a- hexahydroisoindole compounds |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4120646A DE4120646A1 (de) | 1991-06-22 | 1991-06-22 | 7-isoindolinyl-chinolon- und naphthyridoncarbonsaeure-derivate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL102261A0 IL102261A0 (en) | 1993-01-14 |
| IL102261A true IL102261A (en) | 1996-10-16 |
Family
ID=6434522
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL10226192A IL102261A (en) | 1991-06-22 | 1992-06-19 | History of 7-Isoindolinyl-Quinolenic and Naphthyridonecarboxylic Acids, Preparation and Preparation of Pharmaceuticals Containing Them |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US5464796A (cs) |
| EP (1) | EP0520240A1 (cs) |
| JP (1) | JPH05239051A (cs) |
| KR (1) | KR930000503A (cs) |
| CN (1) | CN1068115A (cs) |
| AU (1) | AU648669B2 (cs) |
| CA (1) | CA2071677A1 (cs) |
| CZ (1) | CZ190192A3 (cs) |
| DE (1) | DE4120646A1 (cs) |
| FI (1) | FI922873A (cs) |
| HU (1) | HUT62288A (cs) |
| IE (1) | IE922003A1 (cs) |
| IL (1) | IL102261A (cs) |
| MX (1) | MX9202982A (cs) |
| NO (1) | NO922226L (cs) |
| NZ (1) | NZ243214A (cs) |
| PH (1) | PH30227A (cs) |
| RU (1) | RU2056411C1 (cs) |
| SK (1) | SK190192A3 (cs) |
| TW (1) | TW202442B (cs) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4230804A1 (de) * | 1992-09-15 | 1994-03-17 | Bayer Ag | 7-Isoindolinyl-chinolon- und -naphthyridon-Derivate |
| US5527910A (en) * | 1992-12-30 | 1996-06-18 | Cheil Foods & Chemicals, Inc. | Pyridone carboxylic acid compounds and their uses for treating infectious diseases caused by bacteria |
| DE4301246A1 (de) * | 1993-01-19 | 1994-07-21 | Bayer Ag | Chinolon- und Naphthyridoncarbonsäurederivate |
| US5532239A (en) * | 1993-08-02 | 1996-07-02 | Assistance Publique - Hopitaux De Paris | Therapeutic application of fluoroquinolone derivatives |
| DE4329600A1 (de) * | 1993-09-02 | 1995-03-09 | Bayer Ag | Pyrido [1,2,3-d,e] [1,3,4] benzoxadiazinderivate |
| DE4418510A1 (de) * | 1994-05-27 | 1995-11-30 | Bayer Ag | 1,9-überbrückte Thiazolol[3,4-a]chinolinderivate |
| DE4427530A1 (de) | 1994-08-04 | 1996-02-08 | Bayer Ag | Chinolon- und Naphthyridoncarbonsäure-Derivate |
| DE4435479A1 (de) | 1994-10-04 | 1996-04-11 | Bayer Ag | Chinolon- und Naphthyridoncarbonsäure-Derivate |
| DE19500792A1 (de) * | 1995-01-13 | 1996-07-18 | Bayer Ag | Chinolon- und Naphthyridoncarbonsäure-Derivate |
| JPH08213881A (ja) * | 1995-02-02 | 1996-08-20 | Fujitsu Ltd | 周波数制御回路 |
| DE19506535A1 (de) * | 1995-02-09 | 1996-08-14 | Bayer Ag | 1,6-Naphthyridoncarbonsäurederivate |
| DE19512484A1 (de) * | 1995-04-04 | 1996-10-17 | Bayer Ag | Kohlenhydratmodifizierte Cytostatika |
| AU735186B2 (en) * | 1997-09-15 | 2001-07-05 | Warner Chilcott Company, Llc | Antimicrobial quinolones, their compositions and uses |
| PA8466701A1 (es) | 1998-01-21 | 2000-09-29 | Pfizer Prod Inc | Comprimido de mesilato de trovafloxacino |
| US7220824B1 (en) | 2000-08-28 | 2007-05-22 | Bayer Aktiengesellschaft | Integrin-mediated drug targeting |
| EP1219634A1 (en) * | 2000-12-27 | 2002-07-03 | Bayer Aktiengesellschaft | Cytostatic-glycoconjugates having specifically cleavable peptidic linking units |
| EP1238678A1 (en) | 2001-03-08 | 2002-09-11 | Bayer Aktiengesellschaft | Enzyme-activated cytostatic conjugates with integrin ligands |
| US20070196398A1 (en) * | 2006-02-17 | 2007-08-23 | Murthy Yerramilli V S | Fluoroquinolone fatty acid salt compositions |
| US7973022B2 (en) | 2006-02-17 | 2011-07-05 | Idexx Laboratories, Inc. | Fluoroquinolone carboxylic acid salt compositions |
| US20070197548A1 (en) | 2006-02-17 | 2007-08-23 | Murthy Yerramilli V S | Fluoroquinolone compositions |
| KR101084521B1 (ko) * | 2006-03-28 | 2011-11-18 | 워너 칠콧 컴퍼니 엘엘씨 | 퀴놀론 중간체를 제조하기 위한 커플링 방법 |
| MX2008012328A (es) * | 2006-03-28 | 2008-10-09 | Procter & Gamble | Sales de malato, y polimorfos de acido (3s,5s)-7-[3-amino-5-metil- piperidinil]-1-ciclopropil-1,4-dihidro-8-metoxi-4-oxo-3-quinolinc arboxilico. |
| KR100690084B1 (ko) * | 2006-11-01 | 2007-03-09 | 주식회사 세홍이엔씨 | 출입문과 연동하는 주택 내 배전반 |
| WO2013111158A2 (en) * | 2012-01-03 | 2013-08-01 | Msn Laboratories Limited | Process for the preparation of dpp-iv inhibitor |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5746986A (en) * | 1980-09-02 | 1982-03-17 | Dai Ichi Seiyaku Co Ltd | Pyrido(1,2,3-de)(1,4)benzoxazine derivative |
| NZ208470A (en) * | 1983-07-18 | 1988-06-30 | Abbott Lab | 6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid derivatives and antibacterial compositions containing such |
| EP0154780B1 (en) * | 1984-01-26 | 1990-04-11 | Abbott Laboratories | Quinoline antibacterial compounds |
| NZ210847A (en) * | 1984-01-26 | 1988-02-29 | Abbott Lab | Naphthyridine and pyridopyrimidine derivatives and pharmaceutical compositions |
| DE3420743A1 (de) * | 1984-06-04 | 1985-12-05 | Bayer Ag, 5090 Leverkusen | 7-amino-1-cyclopropyl-6,8-dihalogen-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel |
| GB8612137D0 (en) * | 1986-05-19 | 1986-06-25 | Fujisawa Pharmaceutical Co | Quinolone compounds |
| JP2844079B2 (ja) * | 1988-05-23 | 1999-01-06 | 塩野義製薬株式会社 | ピリドンカルボン酸系抗菌剤 |
| JPH0262875A (ja) * | 1988-05-23 | 1990-03-02 | Wakunaga Pharmaceut Co Ltd | 新規イソインドリン誘導体 |
| DE3906365A1 (de) * | 1988-07-15 | 1990-01-18 | Bayer Ag | 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe |
| DE3910663A1 (de) * | 1989-04-03 | 1990-10-04 | Bayer Ag | 5-alkylchinoloncarbonsaeuren |
| JPH04504852A (ja) * | 1989-04-26 | 1992-08-27 | ジ・アップジョン・カンパニー | 抗菌性ピリド（１，２，３―デ）―１，４―ベンゾオキサジノン剤 |
| CA2030217A1 (en) * | 1989-11-21 | 1991-05-22 | Jun Imose | Pyridone-carboxylic acid derivatives useful as veterinary medicines |
-
1991
- 1991-06-22 DE DE4120646A patent/DE4120646A1/de not_active Withdrawn
-
1992
- 1992-05-22 TW TW081103997A patent/TW202442B/zh active
- 1992-06-03 AU AU17391/92A patent/AU648669B2/en not_active Ceased
- 1992-06-05 NO NO92922226A patent/NO922226L/no unknown
- 1992-06-10 EP EP92109742A patent/EP0520240A1/de not_active Withdrawn
- 1992-06-11 US US07/896,955 patent/US5464796A/en not_active Expired - Fee Related
- 1992-06-17 PH PH44526A patent/PH30227A/en unknown
- 1992-06-18 MX MX9202982A patent/MX9202982A/es unknown
- 1992-06-18 FI FI922873A patent/FI922873A/fi unknown
- 1992-06-19 NZ NZ243214A patent/NZ243214A/en unknown
- 1992-06-19 CA CA002071677A patent/CA2071677A1/en not_active Abandoned
- 1992-06-19 RU SU925052282A patent/RU2056411C1/ru active
- 1992-06-19 SK SK1901-92A patent/SK190192A3/sk unknown
- 1992-06-19 CZ CS921901A patent/CZ190192A3/cs unknown
- 1992-06-19 IL IL10226192A patent/IL102261A/en not_active IP Right Cessation
- 1992-06-19 JP JP4184679A patent/JPH05239051A/ja active Pending
- 1992-06-20 KR KR1019920010775A patent/KR930000503A/ko not_active Application Discontinuation
- 1992-06-22 HU HU9202085A patent/HUT62288A/hu unknown
- 1992-06-22 CN CN92104849A patent/CN1068115A/zh active Pending
- 1992-07-01 IE IE200392A patent/IE922003A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR930000503A (ko) | 1993-01-15 |
| IE922003A1 (en) | 1992-12-30 |
| CN1068115A (zh) | 1993-01-20 |
| TW202442B (cs) | 1993-03-21 |
| AU648669B2 (en) | 1994-04-28 |
| RU2056411C1 (ru) | 1996-03-20 |
| HU9202085D0 (en) | 1992-09-28 |
| HUT62288A (en) | 1993-04-28 |
| SK190192A3 (en) | 1995-08-09 |
| NZ243214A (en) | 1995-07-26 |
| CZ190192A3 (en) | 1993-01-13 |
| MX9202982A (es) | 1992-12-01 |
| NO922226L (no) | 1992-12-23 |
| DE4120646A1 (de) | 1992-12-24 |
| IL102261A0 (en) | 1993-01-14 |
| US5464796A (en) | 1995-11-07 |
| EP0520240A1 (de) | 1992-12-30 |
| JPH05239051A (ja) | 1993-09-17 |
| CA2071677A1 (en) | 1992-12-23 |
| PH30227A (en) | 1997-02-05 |
| AU1739192A (en) | 1992-12-24 |
| NO922226D0 (no) | 1992-06-05 |
| FI922873A0 (fi) | 1992-06-18 |
| FI922873A (fi) | 1992-12-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL102261A (en) | History of 7-Isoindolinyl-Quinolenic and Naphthyridonecarboxylic Acids, Preparation and Preparation of Pharmaceuticals Containing Them | |
| AU647627B2 (en) | 7-Azaisoindolinyl-quinolone- and-naphthyridonecarboxylic acid derivatives | |
| AU674272B2 (en) | Intermediates for the manufacture of 6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acids | |
| RU2114832C1 (ru) | Производные хинолон- и нафтиридон-карбоновой кислоты в виде смеси изомеров или отдельных изомеров, их соли | |
| JPH05271229A (ja) | キノロン−およびナフチリドン−カルボン酸誘導体類 | |
| HU196986B (en) | Process for producing new naphtiridine- and quinoline-carboxylic acids of antibacterial activity and pharmaceutical compositions containing them | |
| AU658901B2 (en) | 8-vinyl- and 8-ethinyl-quinolone-carboxylic acids | |
| CZ288493B6 (en) | Derivatives of 7-isoindolinylquinolone and 7-isoindolinylnaphthyridone, process of their preparation, intermediates for their preparation, their use as well as medicaments in which the derivatives are comprised | |
| US5679689A (en) | Quinolone- and naphthyridonecarboxylic acid derivatives | |
| US5621105A (en) | Preparation of 7-(aminomethyl-oxa-7-aza-bicyclo[3.3.0]oct-7-yl) quinolonecarboxylic and 7-(aminomethyl-oxa-7-aza-bicyclo[3.3.0]oct-7-yl naphthyridonecarboxylic acid derivatives | |
| US5753669A (en) | Quinolone--and naphthyridonecarboxylic acid derivatives | |
| NZ250005A (en) | 4-amino-hexahydroisoindoles as process intermediates |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| RH | Patent void |